文献速递妇科生殖医学

孕激素受体B预测年轻女性非典型子宫内膜增生和早期子宫内膜癌保守治疗结局的准确性

Predictive Accuracy of Progesterone Receptor B in Young Women with Atypical Endometrial Hyperplasia and Early Endometrial Cancer Treated with Hysteroscopic Resection plus LNG-IUD Insertion.
PubMed 文献 · J Minim Invasive Gynecol · 2020-10-26

结果显示,间质PRB弱表达对治疗失败、无消退和复发均具有100%的敏感性,腺体PRB弱表达则具有中等预测准确性。

要点

  • 间质PRB弱表达预测治疗失败、无消退和复发的敏感性均为100%。
  • 腺体PRB弱表达预测治疗失败的敏感性为70%,特异性为77%。
  • PRB免疫组化可用于筛选适合保守治疗的AEH/EEC患者。

核心结论

  • 间质PRB弱表达是预测AEH和EEC保守治疗后无反应和复发的高敏感性标志物。

主要发现

  • 腺体PRB弱表达预测治疗失败的敏感性70%、特异性77%、AUC=0.74;预测无消退的敏感性66.7%、特异性70%、AUC=0.68;预测复发的敏感性75%、特异性68.8%、AUC=0.72。
  • 间质PRB弱表达预测治疗失败的敏感性100%、特异性53.8%、AUC=0.77;预测无消退的敏感性100%、特异性46.7%、AUC=0.73;预测复发的敏感性100%、特异性43.8%、AUC=0.72。

临床怎么用

  • 对接受宫腔镜切除联合LNG-IUD保守治疗的AEH/EEC年轻患者,可检测PRB表达,尤其间质弱表达者需加强随访监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY OBJECTIVE: The immunohistochemical expression of isoform B of the progesterone receptor (PRB) has shown promising results in predicting the response of atypical endometrial hyperplasia (AEH) and early endometrial cancer (EEC) to conservative treatment. We aimed to calculate the accuracy of PRB as a predictive marker of conservative treatment outcome in AEH or EEC. DESIGN: Retrospective cohort study. SETTING: University of Naples Federico II, Naples, Italy. PATIENTS: Thirty-six consecutive premenopausal women <45 years of age with AEH (n = 29) or EEC (n = 7) conservatively treated from January 2007 to June 2018 were retrospectively assessed. INTERVENTIONS: All patients had been treated with hysteroscopic resection plus levonorgestrel-releasing intrauterine device insertion and followed for at least 1 year. The immunohistochemical expression of PRB was separately assessed in the glands and stroma of the lesion and dichotomized as "weak" or "normal." MEASUREMENT AND MAIN RESULTS: The treatment outcomes considered were (1) treatment failure (i.e., a combined outcome including no regression or recurrence); (2) no regression; and (3) recurrence. The predictive accuracy of PRB immunohistochemistry was assessed by calculating sensitivity (SE), specificity (SP), and area under the receiver operating characteristic curve (AUC). A weak glandular PRB expression showed SE = 70%, SP = 77%, and AUC = 0.74 for treatment failure; SE = 66.7%, SP = 70%, and AUC = 0.68 for no regression; and SE = 75%, SP = 68.8%, and AUC = 0.72 for recurrence. A weak stromal PRB expression showed SE = 100%, SP = 53.8%, and AUC = 0.77 for treatment failure; SE = 100%, SP = 46.7%, and AUC = 0.73 for no regression; and SE = 100%, SP = 43.8%, and AUC = 0.72 for recurrence. CONCLUSION: A weak stromal PRB expression is a highly sensitive predictive marker of both no response and recurrence of AEH and EEC conservatively treated.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Raffone A, Travaglino A, Zullo FM, et al. Predictive Accuracy of Progesterone Receptor B in Young Women with Atypical Endometrial Hyperplasia and Early Endometrial Cancer Treated with Hysteroscopic Resection plus LNG-IUD Insertion. J Minim Invasive Gynecol. 2020. PMID: 33122144. doi:10.1016/j.jmig.2020.10.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。